Question
Is NMN (nicotinamide mononucleotide) legit?
In context of NMN (nicotinamide mononucleotide)·Insufficient evidence56/100
In our editorial model, NMN (nicotinamide mononucleotide) maps to a Insufficient evidence verdict at 56/100 overall (evidence 48/100, safety 72/100, hype gap 64/100). NAD+ precursor marketing; Longevity stacks. Typical label framing: Human dosing not standardized; studies used hundreds of mg/day in small trials.
Full ingredient file
This page is a short answer. Mechanisms, dosing notes, sources, and the rest of the verdict live on the hub for NMN (nicotinamide mononucleotide).
Open NMN (nicotinamide mononucleotide) verdictOther questions on NMN (nicotinamide mononucleotide)
A few more focused pages for the same ingredient (we keep lists short on purpose).